Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 6.75% | 131.47 | 0.7% | $2064.77m | |
| PFE | Pfizer Inc. | 2.33% | 31.62 | 0.9% | $1465.21m | |
| MRK | Merck & Co., Inc. | 5.34% | 75.56 | 0.7% | $1362.61m | |
| ABBV | AbbVie, Inc. | 2.81% | 74.71 | 2.3% | $1247.19m | |
| BMY | Bristol-Myers Squibb Co. | 2.55% | 54.14 | 1.0% | $1089.88m | |
| LLY | Eli Lilly & Co. | 2.56% | 137.54 | 1.1% | $919.33m | |
| FTSV | Forty Seven, Inc. | 0.88% | 95.38 | 0.0% | $327.50m | |
| NVS | Novartis AG | 2.18% | 81.01 | 0.2% | $320.73m | |
| GSK | GlaxoSmithKline Plc | 1.87% | 37.12 | 0.2% | $281.80m | |
| AZN | AstraZeneca Plc | 3.47% | 43.95 | 1.2% | $277.68m | |
| NVO | Novo Nordisk A/S | 4.95% | 59.54 | 0.1% | $175.10m | |
| SNY | Sanofi | 5.02% | 44.57 | 0.2% | $166.29m | |
| BHC | Bausch Health Cos., Inc. | -0.75% | 14.40 | 0.0% | $103.36m | |
| RGEN | Repligen Corp. | 2.81% | 95.15 | 7.1% | $74.52m | |
| RETA | Reata Pharmaceuticals, Inc. | 2.35% | 153.52 | 3.4% | $69.11m |
Company Profile
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.